<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "cystic fibrosis" and "editing" OR "therapy" OR "therapies"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31940495">Link</a></p><p><b>Date:</b> 01/15/2020</p><p><b>Authors:</b> Karyn Schmidt ...  Carl D Novina</p><p><b>Journal:</b> Cell Rep</p><p><b>IF (7 or above):</b> 7.70</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Long non-coding RNAs (lncRNAs) are critical regulators of numerous physiological processes and diseases, especially cancers.  However, development of lncRNA-based therapies is limited because the mechanisms of many lncRNAs are obscure, and interactions with functional partners, including proteins, r ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Hypertension.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31060074">Link</a></p><p><b>Date:</b> 05/06/2019</p><p><b>Authors:</b> James Brian Byrd ...  Robert D Brook</p><p><b>Journal:</b> Ann. Intern. Med.</p><p><b>IF (7 or above):</b> 11.75</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Recent guidelines on diagnosis and management of high blood pressure (BP) include substantial changes and several new concepts compared with previous guidelines.  These are reviewed and their clinical implications are discussed in this article.</p></div></td></div></tr></table></div><hr></div></body></html>